Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded
- Contract number
- SPE2DR26FMDT6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,220
Award facts
- Contract value 100% obligated
- $20,220.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,220 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 mL vials. The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, contains no set-aside designation, indicating the award was made through competitive procurement. DMS Pharmaceutical Group Inc. will serve as the sole contractor, with no identified subcontractors participating in this delivery order.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a ceiling value of $499.999 billion through December 31, 2036. The PPV-G GEN V program, part of a broader $30.3 billion acquisition strategy, establishes regional prime vendor contractors to supply pharmaceutical products, biologics, and medical consumables to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system and positions it as a critical supplier within the Defense Logistics Agency's global pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMDT6?
SPE2DR26FMDT6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FMDT6 worth?
The government has obligated $20,220 on SPE2DR26FMDT6.
Is contract SPE2DR26FMDT6 an order under another contract?
Yes. SPE2DR26FMDT6 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDT6 competed?
The extent of competition for SPE2DR26FMDT6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award